Checkmate Pharmaceuticals, Inc Checkmate (NASDAQ: CMPI) Announces its Acquisition by Regeneron Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) disclosed that it has inked a definitive agreement for the purchase of Checkmate by Regeneron at an all-cash price
Regeneron Pharmaceuticals, Inc Regeneron (NASDAQ: REGN) Announces Dupixent Earns Approval from European Commission Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) have confirmed that European Commission has extended the marketing authorization for Dupixent (dupilumab) in the European Union. Dupixent is now authorized
